Cargando…
Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model
We previously reported that withaferin A (WA), a natural compound, deters prostate cancer by inhibiting AKT while inducing apoptosis. In the current study, we examined its chemopreventive efficacy against carcinogenesis in the prostate using the transgenic adenocarcinoma of mouse prostate (TRAMP) mo...
Autores principales: | Suman, Suman, Das, Trinath P., Moselhy, Jim, Pal, Deeksha, Kolluru, Venkatesh, Alatassi, Houda, Ankem, Murali K., Damodaran, Chendil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288218/ https://www.ncbi.nlm.nih.gov/pubmed/27447565 http://dx.doi.org/10.18632/oncotarget.10733 |
Ejemplares similares
-
Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer()()
por: Moselhy, Jim, et al.
Publicado: (2017) -
Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis
por: Pal, Deeksha, et al.
Publicado: (2017) -
Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells
por: Suman, Suman, et al.
Publicado: (2016) -
Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer
por: Das, Trinath P., et al.
Publicado: (2016) -
Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer
por: Das, T P, et al.
Publicado: (2016)